insulin degludec

Known as: (1A-21A),(1B-29B)-insulin (human), 29B-(N6-(N-(15-carboxy-1- oxopentadecyl)-L-gamma- glutamyl)-L-lysine)-, INSULIN,DEGLUDEC,HUMAN/RDNA, degludec 
 

Topic mentions per year

Topic mentions per year

2011-2017
010203020112017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
OBJECTIVES A medical need remains for a once-daily insulin with 24-h basal coverage in all patients. We characterize the steady… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2015
2015
AIMS Insulin degludec/insulin aspart (IDegAsp) is a soluble co-formulation of IDeg and IAsp. This pan-Asian, 26-week trial… (More)
  • figure 1
  • table 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
2015
2015
AIMS To confirm, in a 26-week extension study, the sustained efficacy and safety of a fixed combination of insulin degludec and… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2014
2014
BACKGROUND A fixed-ratio combination of the basal insulin analogue insulin degludec and the glucagon-like peptide-1 (GLP-1… (More)
Is this relevant?
2014
2014
AIM Two treatment strategies were compared in patients with type 2 diabetes (T2DM) on basal insulin requiring intensification… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?
2014
2014
To study the self-association states of insulin degludec and insulin aspart alone and combined in pharmaceutical formulation and… (More)
  • table I
  • figure 1
  • table II
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2013
Highly Cited
2013
OBJECTIVE This study investigated the efficacy and safety of insulin degludec (IDeg) once daily (OD), varying injection timing… (More)
Is this relevant?
2013
2013
AIMS The goal of this study was to compare the long-term safety and efficacy of the basal insulin analogue, insulin degludec with… (More)
Is this relevant?
2013
2013
INTRODUCTION Insulin degludec (IDeg) is an ultra-long-acting basal insulin with a consistent action profile of >42 h. This trial… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2011
2011
BACKGROUND Insulin degludec is a new basal insulin that forms soluble multihexamer assemblies after subcutaneous injection… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?